Stocksigma LogoStocksigma Logo

USFDA Closes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification

Dr. Reddy鈥檚 Laboratories announced that the USFDA has classified the inspection outcome for its FTO-SEZ Process Unit-02 located in Srikakulam, Andhra

USFDA Closes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification

Dr Reddys Laboratories Ltd 路 Others (Uncategorized) 路 28 Oct 2026, 11:59 pm

USFDA Closes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification Dr. Reddy鈥檚 Laboratories announced that the USFDA has classified the inspection outcome for its FTO-SEZ Process Unit-02 located in Srikakulam, Andhra Pradesh, as Voluntary Action Indicated (VAI). The Pre-Approval Inspection (PAI) and Good Manufacturing Practices (GMP) audit, originally intimated on 29th Jul'26, is now officially closed under 21 CFR 20.64(d)(3). The VAI status removes regulatory overhang for the facility, clearing a key compliance hurdle for pending and future US product approvals from the site.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements